Table 2.
Antimicrobial susceptibility of P. aeruginosa isolated from hospitals of Qazvin and Alborz provinces
|
Number (%) | |||
|---|---|---|---|
| Antibiotics | Resistant | Intermediate | Susceptible |
| Cefotaxime | (7%.52)158 | (40%)120 | (3%.7)22 |
| Aztreonam | (36%) 115 | (21.7%) 65 | (40%) 120 |
| Carbenicillin | (7%.51)155 | (7%.4)14 | (7%.43)131 |
| Levofloxacin | (7%.48)146 | (2%)6 | (3%.49)148 |
| Ofloxacin | (47%)141 | (7%.3)11 | (3%.49)148 |
| Ticarcillin | (3%.47)142 | (3%.2) 7 | (3%.50)151 |
| Ciprofloxacin | (3%.43)130 | (7%.3)11 | (53%)159 |
| Gentamicin | (7%.44)134 | (3%.1)4 | (54%)162 |
| Tobramycin | (7%.42)128 | (7%.1)5 | (7%.55)167 |
| Ceftazidime | (37%)111 | (3%.5)16 | (7%.57)173 |
| Piperacillin | (3%.32)97 | (7%.9)29 | (58%)174 |
| Meropenem | (35%)105 | (3%.5)16 | (7%.59)179 |
| Imipenem | (31%)93 | (7%)21 | (62%)186 |
| Cefepime | (33%) 99 | (4%)12 | (63%) 189 |
| Piperacillin/tazobactam | (7%.25)77 | (9.7%)29 | (64.7%)194 |
| Amikacin | (38.3%) 62 | (8%)24 | (71.3%) 214 |
| Polymyxin B | (1.7%)5 | 0 | (3%.98)295 |